Aveanna Healthcare Q2 2023 Earnings Report

Aveanna Healthcare EPS Results

• Actual EPS: -$0.02
• Consensus EPS: -$0.04
• Beat/Miss: Beat by +$0.02
• One Year Ago EPS: $0.03

Aveanna Healthcare Revenue Results

• Actual Revenue: $471.95 million
• Expected Revenue: $453.19 million
• Beat/Miss: Beat by +$18.76 million
• YoY Revenue Growth: N/A

Aveanna Healthcare Announcement Details

• Quarter: Q2 2023
• Date: 8/10/2023
• Time: Before Market Opens

Aveanna Healthcare (NASDAQ:AVAH), a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.